INS and metabolic syndrome: The fact that a lower II in MetS patients than in control obese subjects prevailed in diabetic MetS patients, but not so in non-diabetic MetS patients, apparently argues in favor of the second hypothesis mentioned in the preceding sentence, i.e., a decrease of the pancreatic insulin stores otherwise available to ensure a suitable release of insulin.